BeWo‐Derived Extracellular Vesicles Downregulate IL‐6R α Expression via miRNAs on CD4+ T Lymphocytes
American Journal of Reproductive Immunology · 2026
DOI: 10.1111/aji.70335 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Reproductive Immunology, 2026. Verfasst von Gábor Seregélyes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary. Hauptthemen laut MEDLINE: MicroRNAs, Extracellular Vesicles, CD4-Positive T-Lymphocytes, Trophoblasts. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: STIA_2024.
Abstract (Originalsprache)
Problem A balanced Th1/Th2/Th17/Treg status is necessary for a successful pregnancy. T cell polarization depends on the local cytokine environment and the responsiveness of T lymphocytes to cytokines. Trophoblast‐derived extracellular vesicles (EVs) influence the function of maternal T lymphocytes, contributing to their polarization into the Treg phenotype. We examined whether BeWo‐derived EVs affect T cell IL‐6 responsiveness using the BeWo cell line as an experimental model and characterized the molecular cargo of BeWo ‐EVs that may contribute to this process.
Methods
Circulating lymphocytes from non‐pregnant women were treated with BeWo‐EVs or co‐cultured with BeWo cells. We detected IL‐6R α expression by flow cytometry and IL6R signaling pathways by RT‐PCR. The microRNA (miRNA) content of BeWo EVs was identified by sequencing. Finally, we compared IL‐6R α expression levels in circulating T lymphocytes from healthy pregnant and non‐pregnant women.
Results
BeWo‐EVs reduced IL‐6R α expression on CD4+ T cells. This modifies the IL‐6 pathway by downregulating the transcription factors STAT3, NFKB1, and PIAS3 while upregulating STAT1. This may be due to the presence of specific microRNAs (miRNAs), such as hsa‐mir‐92a‐3p, hsa‐mir‐520f‐3p, and hsa‐mir‐25‐3p, in BeWo‐EVs that target the IL‐6 pathway. Treatment with BeWo‐EVs also induced phenotypic and functional changes in T cells and enhanced the ratio of CD4+/CD25+ T cells that produce IL‐10. Pregnancy‐associated IL‐6R α downregulation has been demonstrated in clinical samples. Significantly lower levels of IL‐6R α were detected on circulating CD4+CD25+ T cells in healthy pregnant women compared to healthy non‐pregnant individuals.
Conclusions
Our studies suggest that the microRNA content of trophoblast‐derived EVs significantly influences the local polarization of maternal T lymphocytes by modifying the IL‐6R α signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary.
- Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
- Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
- MTA-SE Immune-Proteogenomics Extracellular Vesicle Research Group, Budapest, Hungary.
- HCEMM-SE Extracellular Vesicle Research Group, Budapest, Hungary.
ORCID-Profile: Gábor Seregélyes, Árpád Ferenc Kovács, Nóra Fekete, Edit I Buzás, Éva Pállinger
Förderung
- STIA_2024
Zitieren
APA
Seregélyes, G., Nagy, B., Kovács, Á. F., Fekete, N., Buzás, E. I., & Pállinger, É. (2026). BeWo‐Derived Extracellular Vesicles Downregulate IL‐6R α Expression via miRNAs on CD4+ T Lymphocytes. American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.70335
Vancouver
Seregélyes G, Nagy B, Kovács ÁF, Fekete N, Buzás EI, Pállinger É. BeWo‐Derived Extracellular Vesicles Downregulate IL‐6R α Expression via miRNAs on CD4+ T Lymphocytes. American Journal of Reproductive Immunology. 2026. doi:10.1111/aji.70335
BibTeX
@article{Sereglyes2026,
author = {Seregélyes, Gábor and Nagy, Bence and Kovács, Árpád Ferenc and Fekete, Nóra and Buzás, Edit I and Pállinger, Éva},
title = {BeWo‐Derived Extracellular Vesicles Downregulate IL‐6R α Expression via miRNAs on CD4+ T Lymphocytes},
journal = {American Journal of Reproductive Immunology},
year = {2026},
doi = {10.1111/aji.70335}
}
EUVIMED